| Parceiro(s) / Co-promotor(es) / Instituição(ões) participante(s): |
Aarhus Universitet; Acorai AB; Aktiia SA; Arma Biosciences Inc; Association Hospitalière de Bruxelles et de Schaerbeek - Centre Hospitalier Universitaire; Atrys Health S.A.; Bar-Ilan University; BRIDG OU; Datawizard Srl; Exploraciones Radiológicas Especiales S.L.; F. HOFFMANN-LA ROCHE AG; Faculdade de Medicina da Universidade do Porto; Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Forward Faster AI B.V.; Fundación para la Investigación Biomédica del Hospital Gregorio Marañón; Fundación Para La Investigación Biomedica Del Hospital Universitarios La Paz; GE HEALTHCARE AS; GE HEALTHCARE AUSTRIA GMBH & CO OG; GE Healthcare Danmark A/S; GE HEALTHCARE FINLAND OY; GE HEALTHCARE GMBH; GE Healthcare IITS USA Corp.; GE HEALTHCARE MAGYARORSZAG KFT; GE Medical Systems, Israel Ltd; GE Medical Systems Limited; GE MEDICAL SYSTEMS SCS; GE Precision Healthcare LLC; Genomate Health Hungary Kft.; Hadassah Medical Organization; Hict NV; Katholieke Universiteit Leuven; Leiden University Medical Center (LUMC); Multiverse Computing; Norges Teknisk-naturvitenskapelige Universitet - NTNU; Royal Brompton & Harefield hospitals; Servicio Madrileno de Salud; Spear UG; Syreon Research Institute; Telicent Ltd; Themi Consulting BV; Universidad de Navarra; Università della Calabria; Universitatsklinikum Heidelberg; ZABALA INNOVATION CONSULTING SA ES |